STANOZOLOL is an oral androgen derived from dihydrotestosterone. Stanozolol 10 acts on androgen receptors to promote anabolism through increased nitrogen retention and protein synthesis in muscle tissue. Stanozolol is a strong anabolic substance with androgenic action. Stanozolol does not convert to estrogen and therefore does not produce typical estrogen mediated side effects such as water retention. Stanozolol has a large oral bio availability, due to a C17 a-alkylation which allows the hormone to survive first pass liver metabolism. Stanozolol reduces SHBG increasing free testosterone levels.
OXANDROLONE is a well tolerated 17-alpha alkylated anabolic steroid with very low hepatic toxicity. It promotes anabolism through androgen receptor activity and has a low incidence of adverse reactions. When taken in clinical doses, oxandrolone promotes improvements in strength and moderate increases in muscle mass. Oxandrolone has been demonstrated to enhance body fat reduction significantly in both the abdominal and visceral stores . Oxandrolone will not aromatize and therefore the anabolic effect of this compound can promote linear growth. Oxandrolone has shown great promise in nerve regeneration, skin healing in burn victims, and increased rate of healing after traumatic events.